Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Eye Neoplasms × 30 days × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 72 Breast Neoplasms 47 Prostatic Neoplasms 31 Neoplasms 26 Multiple Myeloma 26 Parkinson Disease 4, Autosomal Dominant Lewy Body 20 Lung Neoplasms 20 Leukemia, Lymphocytic, Chronic, B-Cell 18 Ovarian Neoplasms 17 Squamous Cell Carcinoma of Head and Neck 16 Myasthenia Gravis 16 Colorectal Neoplasms 16 Lymphoma, Follicular 15 Leukemia, Myeloid, Acute 15 Neoplasm Metastasis 14 Melanoma 14 Urinary Bladder Neoplasms 12 Stomach Neoplasms 12 Carcinoma, Renal Cell 12 Recurrence 11 Carcinoma 10 Small Cell Lung Carcinoma 9 Non-Muscle Invasive Bladder Neoplasms 9 Glioblastoma 9 Lymphoma, Non-Hodgkin 8 Lymphoma, Large B-Cell, Diffuse 8 Fallopian Tube Neoplasms 8 Endometrial Neoplasms 8 Uterine Cervical Neoplasms 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06007690 2026-03-02

CoMpass

Aura Biosciences

Phase 3 Recruiting

Uveal Melanoma, Eye Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡